{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:06:55Z","timestamp":1789020415440,"version":"build-2803163510"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lung cancer metastasis remains the leading cause of treatment failure and death. Forkhead box C1 (FOXC1) promotes cancer progression, but its definitive mechanism in lung cancer metastasis and druggable potential remain unclear. This study aimed to clarify the mechanism and develop a FOXC1-targeted inhibitor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>FOXC1 expression was analyzed using the HCMDB database. Metastatic function was evaluated using migration and invasion assays and experimental pulmonary metastasis models. Dual-luciferase reporter assays and ChIP-PCR were used to characterize the FOXC1\/\u03b2-catenin feedback loop. Candidate FOXC1-binding compounds were generated using the MolProphet AI platform. Binding was evaluated by SPR and MST, and complex stability was assessed by molecular docking and molecular dynamics simulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>FOXC1 expression was elevated in metastatic lung cancer lesions. FOXC1 directly bound the \u03b2-catenin promoter, whereas \u03b2-catenin-activated TCF4 reciprocally stimulated FOXC1 transcription, forming a self-reinforcing positive-feedback loop. FOXC1-I4 bound FOXC1, reduced FOXC1-dependent reporter activity, and inhibited lung cancer cell migration, invasion, and early pulmonary colonization without significantly affecting cell viability at the tested concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identifies a FOXC1\/\u03b2-catenin positive-feedback loop that promotes lung cancer metastasis and identifies FOXC1-I4 as an AI-designed FOXC1-binding lead compound with anti-metastatic activity in the experimental models used.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1868681","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:31:17Z","timestamp":1789018277000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["FOXC1 drives lung cancer metastasis and functions as a target for AI-enabled anti-metastatic drug discovery"],"prefix":"10.3389","volume":"17","author":[{"given":"Sisi","family":"Cao","sequence":"first","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Peng","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlan","family":"Deng","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Qin","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianpeng","family":"Nong","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhong","family":"He","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meichun","family":"Qin","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tao","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lai","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkai","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyue","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Fourth People\u2019s Hospital of Nanning","place":["Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e10239","DOI":"10.1002\/adma.202510239","article-title":"Artificial intelligence-driven nanoarchitectonics for smart targeted drug delivery","volume":"37","author":"Bae","year":"2025","journal-title":"Adv. Mater"},{"key":"B2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s13046-019-1478-3","article-title":"Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p\/FOXC1 pathway","volume":"38","author":"Bai","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2500156","DOI":"10.1183\/13993003.00156-2025","article-title":"European respiratory society and european society of thoracic surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer","volume":"66","author":"Brunelli","year":"2025","journal-title":"Eur. Respir. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13046-018-0894-0","article-title":"FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC","volume":"37","author":"Cao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1053\/j.gastro.2015.05.058","article-title":"Interleukin-8 induces expression of FOXC1 to promote transactivation of CXCR1 and CCL2 in hepatocellular carcinoma cell lines and formation of metastases in mice","volume":"149","author":"Huang","year":"2015","journal-title":"Gastroenterology"},{"key":"B6","first-page":"1297","article-title":"FOXC1 promotes proliferation and epithelial-mesenchymal transition in cervical carcinoma through the PI3K-AKT signal pathway","volume":"9","author":"Huang","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-025-03441-6","article-title":"This AI method could turbocharge the hunt for new medicines","author":"Ledford","year":"2025","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1093\/nar\/gkae274","article-title":"Proximal telomeric decompaction due to telomere shortening drives FOXC1-dependent myocardial senescence","volume":"52","author":"Li","year":"","journal-title":"Nucleic Acids Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s10565-024-09899-w","article-title":"FOXC1 transcriptionally suppresses ABHD5 to inhibit the progression of renal cell carcinoma through AMPK\/mTOR pathway","volume":"40","author":"Li","year":"","journal-title":"Cell Biol. Toxicol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"115445","DOI":"10.1016\/j.intimp.2025.115445","article-title":"RNF180 suppressed aggressiveness by degrading NOTCH1, TRIM24 and FOXC1, and chemoresistance by degrading ACC1 and ACLY in colorectal cancer","volume":"165","author":"Li","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.7150\/thno.17895","article-title":"Tumor hypoxia regulates forkhead box C1 to promote lung cancer progression","volume":"7","author":"Lin","year":"2017","journal-title":"Theranostics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13046-021-01829-6","article-title":"FOXC1 promotes HCC proliferation and metastasis by upregulating DNMT3B to induce DNA hypermethylation of CTH promoter","volume":"40","author":"Lin","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1038\/s41388-018-0355-4","article-title":"Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression","volume":"37","author":"Liu","year":"2018","journal-title":"Oncogene"},{"key":"B14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s42003-025-07989-x","article-title":"Glucocorticoids regulate the expression of Srsf1 through Hdac4\/Foxc1 axis to induce apoptosis of osteoblasts","volume":"8","author":"Luo","year":"2025","journal-title":"Commun. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"141181","DOI":"10.1016\/j.scitotenv.2020.141181","article-title":"Circ0061052 regulation of FoxC1\/Snail pathway via miR-515-5p is involved in the epithelial-mesenchymal transition of epithelial cells during cigarette smoke-induced airway remodeling","volume":"746","author":"Ma","year":"2020","journal-title":"Sci. Total Environ."},{"key":"B16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41580-024-00823-y","article-title":"Mechanistic insights into Wnt-\u03b2-catenin pathway activation and signal transduction","volume":"26","author":"Maurice","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/ijms26041415","article-title":"The role of the fox gene in breast cancer progression","volume":"26","author":"Pei","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"eadw2593","DOI":"10.1126\/sciadv.adw2593","article-title":"The human genetic variant rs6190 unveils Foxc1 and Arid5a as novel prometabolic targets of the glucocorticoid receptor in muscle","volume":"11","author":"Prabakaran","year":"2025","journal-title":"Sci. Adv."},{"key":"B19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41587-024-02143-0","article-title":"A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models","volume":"43","author":"Ren","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1158\/1078-0432.Ccr-25-0338","article-title":"FOXC1 expression predicts capecitabine efficacy in patients with triple-negative breast cancer from the GEICAM_CIBOMA trial","volume":"31","author":"Rojo","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"24631","DOI":"10.1074\/jbc.M112.375865","article-title":"The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression","volume":"287","author":"Sizemore","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1007\/s10620-021-07226-5","article-title":"Overexpression of FOXC1 promotes tumor metastasis by activating the Wnt\/\u03b2-Catenin signaling pathway in gastric cancer","volume":"67","author":"Sun","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e70090","DOI":"10.3322\/caac.70090","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA A Cancer J. Clin."},{"key":"B24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/s1470-2045(25)00431-0","article-title":"Cancer drug discovery at warp speed: can AI deliver?","volume":"26","author":"The Lancet","year":"2025","journal-title":"Lancet Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1126\/science.aad5440","article-title":"Foxc1 reinforces quiescence in self-renewing hair follicle stem cells","volume":"351","author":"Wang","year":"2016","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/jjco\/hyx073","article-title":"miR-582-5p inhibits invasion and migration of salivary adenoid cystic carcinoma cells by targeting FOXC1","volume":"47","author":"Wang","year":"2017","journal-title":"Jpn. J. Clin. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.7150\/thno.45214","article-title":"Identification of a novel microRNA-141-3p\/Forkhead box C1\/\u03b2-catenin axis associated with rheumatoid arthritis synovial fibroblast function in vivo and in vitro","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e35476","DOI":"10.1002\/cncr.35476","article-title":"Survival trends among patients with metastatic non\u2013small cell lung cancer before and after the approval of immunotherapy in the United States: a surveillance, epidemiology, and end results database\u2013based study","volume":"131","author":"Wang","year":"2025","journal-title":"Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12935-026-04227-0","article-title":"Cigarette smoke promotes the progression of non-small cell lung cancer by activating ERK1\/2-FOXC1 axis to induce epithelial-mesenchymal transition","volume":"26","author":"Wang","year":"2026","journal-title":"Cancer Cell Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2289868","DOI":"10.1080\/08916934.2023.2289868","article-title":"Isorhynchophylline attenuates proliferation and migration of synovial fibroblasts via the FOXC1\/\u03b2-catenin axis","volume":"56","author":"Wu","year":"2023","journal-title":"Autoimmunity"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.7150\/ijbs.4769","article-title":"FOXC1 contributes to microvascular invasion in primary hepatocellular carcinoma via regulating epithelial-mesenchymal transition","volume":"8","author":"Xu","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e2409293","DOI":"10.1002\/advs.202409293","article-title":"Recent advancements in lung cancer metastasis prevention based on nanostrategies","volume":"12","author":"Xu","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.omtn.2019.12.027","article-title":"mmu_circ_0000790 is involved in pulmonary vascular remodeling in mice with HPH via MicroRNA-374c-Mediated FOXC1","volume":"20","author":"Yang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1021\/acs.jcim.3c01979","article-title":"MolProphet: a one-stop, general purpose, and AI-Based platform for the early stages of drug discovery","volume":"64","author":"Yang","year":"","journal-title":"J. Chem. Inf. Model"},{"key":"B35","doi-asserted-by":"publisher","first-page":"148079","DOI":"10.1016\/j.gene.2023.148079","article-title":"Research progress on the regulatory mechanisms of FOXC1 expression in cancers and its role in drug resistance","volume":"897","author":"Yang","year":"","journal-title":"Gene"},{"key":"B36","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.2147\/cmar.S259801","article-title":"FOXCUT promotes the proliferation and invasion by activating FOXC1\/PI3K\/AKT pathway in colorectal cancer","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1604998","DOI":"10.3389\/fphar.2025.1604998","article-title":"Progress of targeted FOX family therapy in ovarian cancer","volume":"16","author":"Zhang","year":"","journal-title":"Front. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1016\/j.cell.2025.08.033","article-title":"Epithelial-mesenchymal transition","volume":"188","author":"Zhang","year":"","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","article-title":"Artificial intelligence in drug development","volume":"31","author":"Zhang","year":"","journal-title":"Nat. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"111680","DOI":"10.1016\/j.cellsig.2025.111680","article-title":"FOXC1 promotes EMT and colorectal cancer progression by attracting M2 macrophages via the TGF-\u03b2\/Smad2\/3\/snail pathway","volume":"130","author":"Zhang","year":"","journal-title":"Cell Signal"},{"key":"B41","first-page":"1642","article-title":"FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer","volume":"7","author":"Zhu","year":"2017","journal-title":"Am. J. Cancer Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1868681\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:31:18Z","timestamp":1789018278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1868681\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":41,"alternative-id":["10.3389\/fphar.2026.1868681"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1868681","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1868681"}}